Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
70.31 CAD | +0.75% | -3.14% | +20.89% |
15/04 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
12/04 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.13% | 294B | |
+6.11% | 146B | |
+55.38% | 128B | |
+18.67% | 80.27B | |
+8.77% | 74.75B | |
+20.23% | 62.53B | |
+8.74% | 57.13B | |
+10.61% | 48.14B | |
+27.41% | 34.96B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Scotiabank Upgrades Ovintiv to Sector Outperform from Sector Perform, Adjusts Price Target to $46 from $44